Dose characterization of the new Bebig IsoSeed ® I25.S17 using polymer gel and MRI

Pantelis, E; Baltas, D; Georgiou, E; Karaiskos, P; Lymperopoulou, G; Papagiannis, P; Sakelliou, L; Seimenis, I; Stilliaris, E

dc.contributor.author	Pantelis, E	en
dc.contributor.author	Baltas, D	en
dc.contributor.author	Georgiou, E	en
dc.contributor.author	Karaiskos, P	en
dc.contributor.author	Lymperopoulou, G	en
dc.contributor.author	Papagiannis, P	en
dc.contributor.author	Sakelliou, L	en
dc.contributor.author	Seimenis, I	en
dc.contributor.author	Stilliaris, E	en
dc.date.accessioned	2014-03-01T01:54:55Z
dc.date.available	2014-03-01T01:54:55Z
dc.date.issued	2006	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/27532
dc.subject	Low Energy	en
dc.subject	Magnetic Resonance Image	en
dc.subject	Monte Carlo	en
dc.subject	Spatial Resolution	en
dc.subject	Low Dose Rate	en
dc.subject	Turbo Spin Echo	en
dc.title	Dose characterization of the new Bebig IsoSeed ® I25.S17 using polymer gel and MRI	en
heal.type	journalArticle	en
heal.identifier.primary	10.1016/j.nima.2006.08.139	en
heal.identifier.secondary	http://dx.doi.org/10.1016/j.nima.2006.08.139	en
heal.publicationDate	2006	en
heal.abstract	A new, molybdenum core, 125I interstitial brachytherapy seed is marketed by Bebig GmbH (IsoSeed® I25.S17) and our group has performed its Dosimetric characterization using Monte Carlo (MC) simulation and Thermoluminescence dosimetry (TLD) as recommended by the AAPM TG-43U1 prior to the clinical implementation of new low-energy seeds. This work presents the results of a supplementary experimental dosimetry study performed using	en
heal.journalName	Nuclear Instruments & Methods in Physics Research Section A-accelerators Spectrometers Detectors and Associated Equipment	en
dc.identifier.doi	10.1016/j.nima.2006.08.139	en